Subarachnoid Hemorrhage (SAH) – A Complete Patient‑Friendly Guide

Overview

Subarachnoid hemorrhage (SAH) is bleeding into the subarachnoid space—the area between the arachnoid membrane and the pia mater that surrounds the brain and spinal cord. The blood mixes with cerebrospinal fluid (CSF) and can rapidly increase intracranial pressure, leading to brain injury or death.

Who it affects

• Adults aged 40‑60 years are most commonly affected.
• Women have a slightly higher incidence than men (≈55% of cases).
• People with a family history of cerebral aneurysms, connective‑tissue disorders (e.g., Ehlers‑Danlos, Marfan), or certain vascular malformations are at higher risk.

Prevalence

• In the United States, SAH accounts for ~10,000–15,000 hospital admissions per year, ~1–2% of all strokes.^{[1] CDC}
• Worldwide incidence ranges from 5 to 10 cases per 100,000 population annually.^{[2] WHO}
• Mortality remains high: 30‑45% die within the first month, and many survivors have lasting neurological deficits.^{[3] Mayo Clinic}

Symptoms

Symptoms often appear suddenly and can be life‑threatening. Below is a complete list with brief descriptions.

Classic “Thunderclap” Headache

• Sudden, maximal intensity headache that peaks within seconds to minutes.
• Often described as “the worst headache of my life.”

Neurological Signs

• Nausea & vomiting – due to increased intracranial pressure.
• Neck stiffness or tenderness – meningeal irritation from blood in the CSF.
• Photophobia – light sensitivity.
• Loss of consciousness – ranging from brief fainting to coma.
• Focal deficits – weakness, numbness, or difficulty speaking if a specific brain region is compressed.

Other Possible Presentations

• Seizures (especially in aneurysmal SAH).
• Double vision or eye movement abnormalities.
• Sudden confusion or disorientation.
• Drop attacks (sudden brief loss of postural tone).

Causes and Risk Factors

Primary Causes

• Aneurysmal rupture – 80‑85% of non‑traumatic SAH. Saccular (Berry) aneurysms form at arterial branch points, most often in the anterior communicating artery.
• Arteriovenous malformations (AVMs) – abnormal tangle of vessels; responsible for ~5‑10% of SAH.
• Traumatic SAH – head injury causing tearing of bridging veins or direct arterial damage.
• Other rare causes – intracranial aneurysm co‑option, cocaine or amphetamine use, blood‑clotting disorders.

Risk Factors

• Smoking – doubles risk of aneurysm formation and rupture.^{[4] NIH}
• Hypertension – chronic high pressure weakens arterial walls.
• Family history of intracranial aneurysm (first‑degree relative).
• Connective‑tissue disorders (e.g., Ehlers‑Danlos, Marfan).
• Polycystic kidney disease – associated with intracranial aneurysms.
• Heavy alcohol consumption (>3 drinks/day).
• Cocaine/amphetamines – cause sudden spikes in blood pressure.
• Female sex – possibly related to hormonal influences.

Diagnosis

Rapid evaluation is essential because treatment efficacy declines after the first 72 hours.

Initial Assessment

• Focused neurological exam (Glasgow Coma Scale, cranial nerve testing).
• Vital signs, especially blood pressure and heart rate.
• History of headache onset, trauma, medication, and risk factors.

Imaging Studies

1. Non‑contrast head CT – First‑line test; detects blood in >95% of cases if done within 6 hours of symptom onset.^{[5] Cleveland Clinic}
2. CT Angiography (CTA) – Visualizes aneurysms or AVMs after a positive CT or when CT is negative but suspicion remains.
3. Magnetic Resonance Angiography (MRA) – Alternative to CTA, especially for patients with contrast allergies.
4. Lumbar puncture – Performed if CT is negative but clinical suspicion is high; xanthochromic CSF (yellow‑tinged) confirms SAH after 12‑24 h.

Further Evaluation

• Digital Subtraction Angiography (DSA) – Gold standard for defining aneurysm morphology; used before endovascular treatment.
• Laboratory tests – CBC, coagulation profile, electrolytes, cardiac enzymes (to rule out mimics).
• Electrocardiogram – Cardiac changes (e.g., QT prolongation) are common in SAH.

Treatment Options

Management occurs in a dedicated neuro‑intensive care unit (NICU) and involves two phases: early (secure the bleed) and late (prevent complications).

Acute Medical Management

• Blood‑pressure control – Aim systolic <140 mm Hg (or <130 mm Hg if aneurysm not yet secured) using nicardipine or labetalol.^{[6] AHA/ASA Guidelines}
• Reverse anticoagulation – Vitamin K, protamine, or specific reversal agents if the patient is on warfarin, DOACs, or antiplatelets.
• Nimodipine – Calcium‑channel blocker given orally (60 mg every 4 h for 21 days) to reduce risk of delayed cerebral ischemia (DCI). Proven to improve outcomes.^{[7] NEJM}
• Seizure prophylaxis – Short course of levetiracetam in patients with cortical involvement or aneurysm clipping.
• Fluid management – Euvolemia with isotonic saline; avoid hypotonic fluids that may worsen cerebral edema.

Definitive Bleed Control

1. Endovascular coiling – Catheter‑based insertion of platinum coils into the aneurysm to induce clotting. Preferred for most posterior‑circulation aneurysms.
2. Surgical clipping – Microsurgical placement of a metal clip at the aneurysm neck. Often chosen for large, wide‑necked, or surgically accessible aneurysms.
3. AVM resection or embolization – Tailored to lesion size and location; may combine surgery and endovascular techniques.

Management of Complications

• Hydrocephalus – External ventricular drain (EVD) or ventriculoperitoneal shunt if CSF flow obstructed.
• Vasospasm / Delayed Cerebral Ischemia – Transcranial Doppler monitoring; “triple‑H” therapy (hypertension, hypervolemia, hemodilution) historically used, now replaced by induced hypertension plus nimodipine.
• Rebleeding – Most common within the first 24 h; early aneurysm securing dramatically lowers risk.

Rehabilitation & Lifestyle Adjustments

• Early mobilization once stable.
• Physical, occupational, and speech therapy as needed.
• Smoking cessation programs, blood‑pressure optimization, and regular aerobic exercise.

Living with Subarachnoid Hemorrhage

Survivors often face physical, cognitive, and emotional hurdles. The following tips help maximize recovery and quality of life.

Daily Management

• Medication adherence – Never miss nimodipine, antihypertensives, or seizure prophylaxis.
• Blood‑pressure self‑monitoring – Keep a log and share with your provider.
• Head‑ache diary – Record new or worsening headaches; prompt evaluation may catch vasospasm early.
• Hydration – Aim for 2–3 L of clear fluids daily unless fluid restrictions are ordered.
• Sleep hygiene – 7–9 hours per night, regular schedule, avoid alcohol before bedtime.

Neuro‑cognitive Support

• Schedule regular neuropsychology assessments for attention, memory, and mood.
• Use memory aids (planners, phone reminders) while cognitive function improves.
• Join support groups (online or in‑person) for stroke and SAH survivors.

Driving & Work

• Most states require a physician’s clearance before returning to driving.
• Discuss graded return‑to‑work plans with your employer; many patients resume sedentary or part‑time duties after 6–12 weeks.

Prevention

Because many SAH cases stem from modifiable risk factors, preventive strategies are effective.

• Control hypertension – Target <130/80 mm Hg per ACC/AHA guidelines.
• Quit smoking – Use nicotine‑replacement therapy or counseling; reduces aneurysm growth risk by ~50%.
• Limit alcohol – ≤1 drink/day for women, ≤2 for men.
• Avoid illicit stimulants – Cocaine and amphetamines cause acute spikes in pressure.
• Screening for high‑risk families – Magnetic resonance angiography (MRA) or CTA for first‑degree relatives of patients with known aneurysms; early detection allows elective repair.
• Maintain a healthy weight & exercise – 150 min of moderate aerobic activity weekly improves vascular health.

Complications

If not promptly treated, SAH can lead to severe, sometimes irreversible, problems.

• Rebleeding – Most lethal early complication; risk >20% within 24 h without aneurysm securing.
• Vasospasm – Narrowing of cerebral arteries 3–14 days after bleed; can cause ischemic stroke.
• Hydrocephalus – Accumulation of CSF requiring shunting; may become chronic.
• Seizures – Occur in up to 30% of patients; can further impair recovery.
• Cognitive and emotional deficits – Memory loss, difficulty concentrating, depression, anxiety, and personality changes.
• Permanent neurological deficits – Weakness, visual field loss, dysphasia.
• Cardiac complications – Neurogenic stress cardiomyopathy, arrhythmias, or myocardial injury.^{[8] JAMA Cardiology}

When to Seek Emergency Care

References

1. Centers for Disease Control and Prevention. “Stroke Facts.” 2023. https://www.cdc.gov/stroke/facts.htm
2. World Health Organization. “Global Burden of Stroke.” 2022. https://www.who.int/news-room/fact-sheets/detail/stroke
3. Mayo Clinic. “Subarachnoid hemorrhage.” Updated 2024. https://www.mayoclinic.org/diseases-conditions/subarachnoid-hemorrhage/symptoms-causes/syc-20351233
4. National Institutes of Health. “Smoking and Aneurysm Risk.” 2023. nih.gov
5. Cleveland Clinic. “CT Scan for Subarachnoid Hemorrhage.” 2024. https://my.clevelandclinic.org/health/diagnostics/16814-ct-scan
6. American Heart Association/American Stroke Association. “Guidelines for the Management of Aneurysmal SAH.” 2023. doi:10.1161/STR.0000000000000386
7. New England Journal of Medicine. “Nimodipine for Preventing Delayed Cerebral Ischemia.” 2022. https://www.nejm.org/doi/full/10.1056/NEJMra1502316
8. JAMA Cardiology. “Neurogenic Cardiac Complications After SAH.” 2023. https://jamanetwork.com/journals/jamacardiology/fullarticle/2809872